Peekcell
Urine sample cancer screening
- B2C
- AI-native
About Peekcell
The company offers a painless, non-invasive women's cancer screening test using innovative technology that analyzes urine biomarkers with artificial intelligence for precise detection
Key facts
- Industry
- Biotechnology Research
- Company size
- 1–10 employees
- Headquarters
- Palaiseau, Île-de-France, France
- Founded
- 2023
- Revenue
- $3.5M – $27.4MTamtam estimate
- Website
- peekcell.fr
- linkedin.com/company/peekcell
Peekcell in the news
- Pink October: Peekcell, an École Polytechnique startup, offers an alternat…
Peekcell develops a non-invasive urine test using AI to detect early female cancers, addressing low screening rates in France.
Peekcell at a glance
Peekcell is a B2C company in the Biotechnology Research industry, headquartered in Palaiseau, Île-de-France, France.
Peekcell was founded in 2023.
Peekcell has 1–10 employees.
Peekcell's revenue is $3.5M – $27.4M (Tamtam estimate).
Selling to companies like Peekcell?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies